Crossmark Global Holdings, Inc. Rx Sight, Inc. Transaction History

Crossmark Global Holdings, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$50.42 - $64.29 $12,201 - $15,558	242 Added 3.18%	7,861 $473,000
Q1 2024 May 13, 2024	SELL	$35.51 - $57.92 $181,349 - $295,797	-5,107 Reduced 40.13%	7,619 $393,000
Q4 2023 Feb 13, 2024	BUY	$20.91 - $40.9 $7,464 - $14,601	357 Added 2.89%	12,726 $513,000
Q3 2023 Nov 08, 2023	BUY	$27.05 - $33.37 $334,581 - $412,753	12,369 New	12,369 $327,000

225

32.3M

394K

32K

Ticker RXST
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,638,900
Market Cap $1.24B
Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.